CVS, PBM and DeVaney

CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS taps Ed DeVaney to head Caremark
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to manage increased medical costs. David Joyner, who previously led Caremark, was named CVS president and CEO in October, replacing previous chief executive Karen Lynch.
CVS Health appoints CVS Caremark president
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS Health names Ed DeVaney president of PBM business
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS Caremark taps Ed DeVaney as president of PBM business
DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim president in December 2024, he will report to Prem Shah, group president of CVS Health.
CVS Health Names Ed DeVaney President of CVS Caremark
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
CVS names longtime exec Ed DeVaney president of Caremark
DeVaney led CVS Caremark sales and account management as president, Employer & Health Plans. CVS Health. This story was originally published on Supermarketnews. CVS
CVS names PBM president
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS Health.
CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Modern Healthcare2d
FTC's insulin case against UnitedHealth, CVS, Cigna PBMs advances
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
FTC case against Caremark, Express Scripts, Optum Rx can move forward, judge rules
A Missouri district court judge on Tuesday said stopping the FTC’s suit against the Big Three PBMs would be “against the ...